NOVAHEALTH BIOSYSTEMS LLC has a total of 14 patent applications. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), United States and Hong Kong. Its main competitors in its focus markets pharmaceuticals and macromolecular chemistry and polymers are DILAFORETTE AB, MODUS THERAPEUTICS AB and USTAV EX FARMAKOLOGIE SAV.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 5 | |
#3 | Hong Kong | 3 | |
#4 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Polysaccharides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Naggi Annamaria | 12 |
#2 | Torri Giangiacomo | 11 |
#3 | Naggi Annamaria A | 3 |
#4 | Torri Giangiacomo G | 2 |
Publication | Filing date | Title |
---|---|---|
US2016237178A1 | Derivatives of N-desulfated glycosaminoglycans and use as drugs | |
US2016297896A1 | Carboxylated derivatives of glycosaminoglycans and use as drugs |